Neurology and Therapy

Scope & Guideline

Unlocking Insights into Neurological Disorders and Treatments

Introduction

Delve into the academic richness of Neurology and Therapy with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2193-8253
PublisherSPRINGER LONDON LTD
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 2012 to 2024
AbbreviationNEUROL THER / Neurol. Ther.
Frequency2 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND

Aims and Scopes

The journal "Neurology and Therapy" is dedicated to advancing the understanding and treatment of neurological disorders through innovative research and clinical studies. The journal covers a broad spectrum of topics related to neurology, emphasizing patient-centered approaches, therapeutic interventions, and the integration of novel methodologies in clinical practice.
  1. Neurological Disorders and Treatments:
    The journal focuses on a wide range of neurological conditions including Alzheimer's disease, multiple sclerosis, Parkinson's disease, epilepsy, and migraine, with a commitment to exploring both pharmacological and non-pharmacological treatments.
  2. Patient-Centric Research:
    A significant emphasis is placed on understanding patient experiences, treatment preferences, and quality of life. Research often incorporates qualitative methods to gauge patient perspectives on their conditions and treatments.
  3. Innovative Therapeutic Approaches:
    The journal highlights advancements in treatment modalities, including novel drug therapies, biologics, and emerging technologies such as deep brain stimulation and virtual reality interventions.
  4. Real-World Evidence and Clinical Practice:
    Research published often includes real-world studies and meta-analyses that assess the effectiveness and safety of treatments in diverse patient populations, thereby bridging the gap between clinical trials and everyday clinical practice.
  5. Biomarkers and Diagnostic Tools:
    The journal explores the development and application of biomarkers and diagnostic methods that aid in the early detection and management of neurological disorders, enhancing personalized treatment strategies.
The landscape of research within "Neurology and Therapy" is evolving, with several themes gaining traction in recent years. This section highlights the emerging scopes that reflect current trends and future directions in neurological research.
  1. Real-World Evidence and Patient Outcomes:
    There is a growing trend towards studies that utilize real-world data to assess the effectiveness and safety of treatments, emphasizing the importance of patient outcomes and experiences in clinical decision-making.
  2. Telehealth and Digital Therapeutics:
    The rise of telehealth and digital therapeutic interventions has become a focal point, particularly in the context of the COVID-19 pandemic, as researchers explore their efficacy in managing neurological conditions.
  3. Personalized Medicine and Biomarkers:
    Research focusing on personalized medicine, particularly the use of biomarkers to tailor treatments to individual patient profiles, is increasingly prominent, reflecting advancements in genetic and molecular research.
  4. Multimodal Approaches to Treatment:
    An emerging trend is the exploration of multimodal treatment strategies that combine pharmacological, behavioral, and rehabilitation therapies, aiming for a more holistic approach to patient care.
  5. Neuroinflammation and Neurodegeneration Research:
    There is a notable increase in studies investigating the role of neuroinflammation in various neurological disorders, as researchers seek to uncover new therapeutic targets and mechanisms.

Declining or Waning

While "Neurology and Therapy" continues to thrive in numerous research areas, certain themes have shown a decline in frequency or prominence in recent publications. These waning scopes may reflect shifting research priorities or advancements in alternative therapeutic strategies.
  1. Traditional Pharmacotherapy for Chronic Conditions:
    There is a noticeable reduction in studies focusing solely on traditional pharmacological approaches to chronic neurological conditions, as the field increasingly embraces combination therapies and integrative treatment models.
  2. Basic Science Research:
    Research articles centered on basic science or purely mechanistic studies are becoming less frequent, possibly due to a shift in focus towards clinical applications and real-world effectiveness.
  3. Longitudinal Studies:
    The prevalence of longitudinal studies examining the long-term outcomes of treatments appears to be decreasing, potentially replaced by more immediate efficacy studies or innovative trial designs.
  4. Conventional Rehabilitation Approaches:
    There is a decline in publications focused on conventional rehabilitation methods, as newer technologies and therapeutic approaches (like virtual reality) gain traction in the field.
  5. Epidemiological Studies of Rare Neurological Disorders:
    Research on rare neurological disorders has seen a decrease, possibly due to the challenges in recruiting large cohorts and the increasing focus on more prevalent conditions or conditions with broader impact.

Similar Journals

Ideggyogyaszati Szemle-Clinical Neuroscience

Bridging Historical Knowledge with Modern Discoveries
Publisher: LITERATURA MEDICAISSN: 0019-1442Frequency: 12 issues/year

Ideggyogyaszati Szemle-Clinical Neuroscience, an esteemed publication under the auspices of LITERATURA MEDICA, serves as a pivotal platform in the field of neurology and clinical neuroscience. Established in Hungary, this journal has been committed to advancing the understanding of neurological disorders and treatments since its inception. With its ISSN 0019-1442 and E-ISSN 2498-6208, it provides a unique local perspective alongside valuable contributions to the global discourse in neuroscience. Despite earning a Q4 quartile ranking in both Neurology and Clinical Neurology, the journal remains dedicated to publishing high-quality research that contributes to the scientific community's collective knowledge. Its coverage spans significant converged years from 1954 to 1985 and now continues through 2024, reflecting a rich historical foundation. Recognizing the importance of open access, the journal strives to enhance accessibility, albeit currently lacking a formal open-access model. Researchers, professionals, and students in the field will find in Ideggyogyaszati Szemle a resource vital for keeping abreast of emerging trends and findings in neurological science.

Current Journal of Neurology

Advancing neurology through open dialogue.
Publisher: TEHRAN UNIV MEDICAL SCIENCESISSN: 2717-011XFrequency: 4 issues/year

Current Journal of Neurology, published by Tehran University of Medical Sciences, is an esteemed Open Access journal dedicated to advancing the field of neurology. Since its inception in 2011, the journal has provided a platform for innovative research and critical discourse in neurology and clinical neurology, with a focus on the latest advancements and methodologies. Although the journal currently holds a Q4 quartile ranking in both neurology and clinical neurology, its goal is to foster the global dissemination of knowledge and ideas relevant to the complexities of neurological disorders. Researchers, professionals, and students exploring this dynamic field will find valuable insights, as the journal aims to bridge the gap between emerging research and clinical application. Based in Tehran, Iran, the Current Journal of Neurology welcomes contributions that enhance understanding and treatment of neurological conditions, thereby promoting evidence-based practices across the globe.

ACTA NEUROLOGICA SCANDINAVICA

Pioneering Research in Neurology
Publisher: WILEYISSN: 0001-6314Frequency: 12 issues/year

ACTA NEUROLOGICA SCANDINAVICA is a prestigious journal published by Wiley that has significantly contributed to the field of neurology and neuroscience since its inception in 1961. With a broad scope encompassing clinical and experimental research, this journal is esteemed for its rigorous peer-review process and high-quality publications. Located in the United Kingdom, it is recognized in the 2023 category quartiles as Q1 in Medicine (miscellaneous) and Q2 in both Neurology and Clinical Neurology, indicating its strong influence and relevance within the medical community. With an H-index demonstrating consistent citation impact, ACTA NEUROLOGICA SCANDINAVICA holds a Scopus rank of #86 out of 400 in Clinical Neurology, reflecting its contribution to advancing current knowledge and practice. Researchers, professionals, and students alike will find in this journal a valuable resource for the latest findings, discussions, and developments in understanding neurological disorders and treatments, furthering educational and clinical endeavors alike.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

Empowering researchers and clinicians in pediatric neurology.
Publisher: ELSEVIER SCI LTDISSN: 1090-3798Frequency: 6 issues/year

European Journal of Paediatric Neurology, published by Elsevier Science Ltd, is a premier academic journal dedicated to advancing the field of paediatric neurology. With its ISSN 1090-3798 and E-ISSN 1532-2130, this journal serves as a vital resource for researchers, clinicians, and students alike, focusing on the latest findings and innovative treatments in paediatric neurological disorders. The journal has established itself as a leading publication in its field, achieving a Q1 classification in Pediatrics, Perinatology and Child Health, and holding a reputable Q2 status in Clinical Neurology as of 2023. Positioned within the top 88th percentile in Pediatrics and the 76th percentile in Clinical Neurology according to Scopus ranks, it publishes rigorous peer-reviewed articles that contribute significantly to clinical practice and research. Although not open access, the journal provides vital insights into the complexities of neurological conditions affecting the pediatric population, making it an essential tool for scholars and professionals striving to improve child health outcomes. With a publication trajectory spanning from 1997 to 2024, it continues to be at the forefront of paediatric neurological research, inspiring innovation and collaboration in the scientific community.

RESTORATIVE NEUROLOGY AND NEUROSCIENCE

Nurturing Knowledge: Bridging Research and Clinical Practice in Neuroscience
Publisher: IOS PRESSISSN: 0922-6028Frequency: 6 issues/year

RESTORATIVE NEUROLOGY AND NEUROSCIENCE, published by IOS PRESS, is a premier journal dedicated to advancing the fields of neurology and neuroscience. Since its inception in 1989, this journal has played a crucial role in disseminating cutting-edge research findings and innovative therapeutic approaches that aim to restore neurological function and improve patient outcomes. With a focus on developmental neuroscience and clinical neurology, the journal holds a 2023 Scopus ranking of #129 out of 400 in clinical neurology, and #15 out of 37 in developmental neuroscience, reflecting its significant influence in these domains. Although it operates on a non-open access model, RESTORATIVE NEUROLOGY AND NEUROSCIENCE offers valuable insights for researchers, healthcare professionals, and students seeking to deepen their understanding of neural restoration mechanisms and therapeutic strategies. Located in Amsterdam, Netherlands, the journal continues to foster scholarly dialogue and innovation, contributing to the global advancement of neuroscience and neurology.

EUROPEAN NEUROLOGY

Advancing the Frontiers of Neurological Science
Publisher: KARGERISSN: 0014-3022Frequency: 6 issues/year

European Neurology, published by KARGER, is a distinguished journal in the field of neurology, catering to both clinical and neuroscience specialties. Since its inception in 1897 and continuing through 2024, the journal has been a vital platform for disseminating significant research findings and insights in neurology. With an ISSN of 0014-3022 and E-ISSN of 1421-9913, it ranks in the Q3 quartile in both clinical neurology and general neurology categories, reflecting its commitment to scholarly excellence while holding the 175th rank in clinical medicine and the 93rd in neuroscience, according to Scopus metrics. European Neurology facilitates a deeper understanding of neurological disorders and treatments, appealing to a diverse readership that includes researchers, clinicians, and students alike. Despite not currently offering open access, the journal’s rigorous peer-review process ensures that only high-quality research reaches its audience, making it an essential resource for those looking to stay informed in the rapidly evolving field of neurology.

Therapeutic Advances in Neurological Disorders

Empowering progress in neurological science and practice.
Publisher: SAGE PUBLICATIONS LTDISSN: 1756-2856Frequency: 1 issue/year

Therapeutic Advances in Neurological Disorders, published by SAGE Publications Ltd, is a leading open access journal dedicated to the advancement of knowledge in the field of neurology. Since its inception in 2008, this journal has established itself as a vital resource for researchers, healthcare professionals, and students, offering a platform for the dissemination of high-quality research that improves the understanding and treatment of neurological disorders. With a commendable impact factor and ranked Q1 in multiple categories, including Neurology and Pharmacology for 2023, it exemplifies excellence in scholarly contributions. The journal's Scope encompasses a wide array of topics, providing insights that are pivotal for clinical practice and pharmacological development. Additionally, with its commitment to open access since 2017, Therapeutic Advances in Neurological Disorders ensures that its research reaches a global audience, fostering collaboration and innovation in neurological science.

Archives of Neuroscience

Advancing neuroscience through innovative research.
Publisher: BRIEFLANDISSN: 2322-3944Frequency: 4 issues/year

Archives of Neuroscience is a multidisciplinary journal dedicated to advancing the field of neuroscience through the publication of original research articles, review papers, and case studies. Published by BRIEFLAND, this journal aims to bridge the gap between neuroscience research and clinical applications, fostering a deeper understanding of brain function, neurological disorders, and potential therapeutic approaches. With an ISSN of 2322-3944 and an E-ISSN of 2322-5769, Archives of Neuroscience serves as an essential platform for researchers, professionals, and students alike, encouraging open access to knowledge and insights that drive innovation in the field. Although coverage was discontinued in Scopus from 2016 to 2017, the journal continues to uphold rigorous standards of academic excellence, making it a valuable resource for the neuroscience community seeking to explore and disseminate new findings. The journal is committed to providing timely access to research tools and findings that are crucial for informed decision-making in both academic and clinical settings.

Multiple Sclerosis International

Elevating discourse, shaping the future of multiple sclerosis research.
Publisher: HINDAWI LTDISSN: 2090-2654Frequency:

Multiple Sclerosis International is a leading open-access journal dedicated to advancing the scientific understanding of multiple sclerosis (MS) and related neurological disorders. Published by HINDAWI LTD since 2010, this journal serves as a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality peer-reviewed articles that cover a diverse range of topics, including epidemiology, treatment strategies, and the latest advancements in MS research. With its commitment to open access, Multiple Sclerosis International ensures that critical findings are readily available to the global community, fostering collaborative efforts to improve patient outcomes and advance therapeutic approaches. The journal not only enhances scholarly discourse in the field but also significantly impacts clinical practices by presenting cutting-edge research and insights.

Degenerative Neurological and Neuromuscular Disease

Championing open access to neurological advancements.
Publisher: DOVE MEDICAL PRESS LTDISSN: Frequency: 1 issue/year

Degenerative Neurological and Neuromuscular Disease is a distinguished academic journal published by DOVE MEDICAL PRESS LTD, focusing on the latest advancements in the field of neurology and neuromuscular disorders. With a commitment to disseminating high-quality research, the journal aims to provide a critical platform for researchers, healthcare professionals, and students to share and engage with groundbreaking studies that advance our understanding of degenerative conditions affecting the nervous system. Although the journal's impact factor and h-index are currently not available, its open access model ensures that the valuable findings published within are accessible to a global audience, thereby fostering collaboration and innovation in neurological health. The journal's address is PO BOX 300-008, Albany, Auckland 0752, New Zealand, reflecting its international relevance and commitment to advancing the field of neurology. As the understanding of neurodegenerative diseases and neuromuscular challenges continues to evolve, Degenerative Neurological and Neuromuscular Disease serves as an essential resource for anyone dedicated to improving patient outcomes and advancing scientific knowledge.